BEIJING, Dec. 13, 2023 /PRNewswire/ — Liangzhu is a sacred place that serves as a testament to the 5,000-year history of Chinese civilization. On December 3, 2023, Liangzhu ancient city once again garnered the world’s attention as it hosted the first Liangzhu Forum, a global dialogue among civilizations. In the meantime, the Global Youth Sharing Meeting on Liangzhu Culture was held in the metaverse. The event was initiated by the Overseas Center (ZTV-WORLD) of ZMG, the UNESCO Beijing Office, and the Liangzhu Culture Youth Promotion Project, together with student representatives from universities across the globe.

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2299836/2023_11_30.mp4’, image: ‘https://mma.prnasia.com/media2/2299836/2023_11_30.mp4?p=medium’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

The sharing meeting held in the metaverse unveiled the trailer of the documentary series Setting out from Liangzhu: Probing the Origins of World Civilizations, which captured a journey starting from Liangzhu in search of world civilization wonders.

This documentary series, with a focus on Liangzhu culture, aims to explore the origins and development of Chinese civilization and foster mutual learning and exchanges across civilizations, leveraging the power of youth to promote global cultural prosperity.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products

SHENZHEN, China, July 18, 2024 /PRNewswire/ — The 90th China International Medical…

Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy

–          The gastrointestinal (GI) tolerability of ASC47 in combination with semaglutide was…

MicroAlgo Inc. Develops Multi-Simulator Collaborative Algorithm Based on Subgraph Isomorphism to Enhance Quantum Computer Performance Using Distributed Computing Advantages

SHENZHEN, China, March 17, 2025 /PRNewswire/ — MicroAlgo Inc. (NASDAQ: MLGO), (the…